Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke

Journal of the Neurological Sciences

Volumn 319, Issue 1-2, 2012, Pages 111-116

  Choi, Kang Ho ^a,b   Park, Man Seok ^a,c   Kim, Joon Tae ^a,c   Chang, Jane ^c   Nam, Tai Seung ^b   Choi, Seong Min ^b   Lee, Seung Han ^c   Kim, Byeong Chae ^c   Kim, Myeong Kyu ^c   Cho, Ki Hyun ^c  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Clinical improvement; Early neurological deterioration; Early outcome; Ischemic stroke; Triglyceride

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84862768773     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.04.018     Document Type: Article

References (39)

1. Imamura T, Doi Y, Arima H, Yonemoto K, Hata J, Kubo M, et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009;40:382-8.
2. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
3. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004;117:596-606. (Pubitemid 39304211)
4. Marti-Fabregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvis R, et al. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 2004;35:1117-21. (Pubitemid 38543528)
5. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005;65:253-8. (Pubitemid 41022370)
6. Weir CJ, Sattar N,Walters MR, Lees KR. Lowtriglyceride, not lowcholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 2003;16:76-82. (Pubitemid 36677000)
7. RyuWS, Lee SH, KimCK, KimBJ, YoonBW. Effects of lowserumtriglyceride on stroke mortality: a prospective follow-up study. Atherosclerosis 2010;212:299-304.
8. Khawaja OA, Hatahet H, Cavalcante J, Khanal S, Al-Mallah MH. Low admission triglyceride and mortality in acute coronary syndrome patients. Cardiol J 2011;18:297-303.
9. Dziedzic T, Slowik A, Gryz EA, Szczudlik A. Lower serum triglyceride level is associated with increased stroke severity. Stroke 2004;35:e151-2.
10. Pikija S, Milevcic D, Trkulja V, Kidemet-Piskac S, Pavlicek I, Sokol N. Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol 2006;55:89-92. (Pubitemid 43760320)
11. Shankar A, Mitchell P, Rochtchina E, Wang JJ. The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: population-based cohort study. Atherosclerosis 2007;192:177-83. (Pubitemid 46602295)
12. Agner E. Some cardiovascular risk markers are also important in old age. Acta Med Scand Suppl 1985;696:3-50.
13. Miller M, Seidler A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 1998;31:1252-7. (Pubitemid 128713120)
14. Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2009;157:548-55.
15. Labreuche J, Touboul PJ, Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis 2009;203:331-45.
16. Lernfelt B, Forsberg M, Blomstrand C, Mellstrom D, Volkmann R. Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population. Stroke 2002;33:224-9. (Pubitemid 34052214)
17. Butterworth RJ, Marshall WJ, Bath PMW. Changes in serum lipid measurements following acute ischaemic stroke. Cerebrovasc Dis 1997;7:10-3. (Pubitemid 27052890)
18. Aull S, Lalouschek W, Schnider P, Sinzinger H, Uhl F, Zeiler K. Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. Am J Med 1996;101:291-8. (Pubitemid 26392442)
19. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, et al. Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998;139:391-9. (Pubitemid 28361825)
20. Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41. (Pubitemid 23014379)
21. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008;39:1647-52.
22. Tissue plasminogen activator for acute ischemic stroke. TheNational Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
23. Brott T, Adams Jr HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70. (Pubitemid 19188240)
24. Ois A, Martinez-Rodriguez JE, Munteis E, Gomis M, Rodriguez-Campello A, Jimenez-Conde J, et al. Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 2008;25:151-6. (Pubitemid 351280390)
25. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32:661-8.
26. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European- Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51. (Pubitemid 28470336)
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
28. Miller M. The epidemiology of triglyceride as a coronary artery disease risk factor. Clin Cardiol 1999;22:II1-6. (Pubitemid 29265093)
29. Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004;35:158-62. (Pubitemid 38057612)
30. Kitayama J, Faraci FM, Lentz SR, Heistad DD. Cerebral vascular dysfunction during hypercholesterolemia. Stroke 2007;38:2136-41. (Pubitemid 47012280)
31. Bradley WA, Song JN, Gianturco SH. Thrombin/prothrombin interactions with very low density lipoproteins. Ann N Y Acad Sci 1986;485:159-69.
32. Denning GM, Figard PH, Kaduce TL, Spector AA. Role of triglycerides in endothelial cell arachidonic acid metabolism. J Lipid Res 1983;24:993-1001. (Pubitemid 13002337)
33. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806. (Pubitemid 34000783)
34. Paolino AS, Garner KM. Effects of hyperglycemia on neurologic outcome in stroke patients. J Neurosci Nurs 2005;37:130-5.
35. Bakker SJ, RG IJ, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 2000;148:17-21.
36. Eryurek FG, Surmen E, Oner P, Altug T, Oz H. Gamma-glutamyl transpeptidase and acetylcholinesterase activities in brain capillaries of cholesterol-fed rabbits. Res Commun Chem Pathol Pharmacol 1990;69:245-8. (Pubitemid 20272365)
37. Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke 2003;34:1450-6.
38. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16. (Pubitemid 47080485)
39. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308. (Pubitemid 47080484)